By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Apotex Inc. 

150 Signet Drive

Toronto  Ontario  M9L 1T9  Canada
Phone: 416-749-9300 or 800-268-4623 Fax: 416-401-3835




Company News
Vanda (VNDA) Settles Fanapt Patent Litigation Wth Apotex 12/8/2016 7:31:44 AM
Apotex Ofloxacin Otic Solution 0.3% Generic Version Of Floxin Otic Now Available 9/27/2016 7:27:43 AM
Apotex Paroxetine Controlled-Release Tablets Authorized Generic Of Paxil CR Now Available 8/25/2016 7:56:53 AM
Apotex Launches Imatinib Tablets Generic Version Of Novartis AG (NVS)'s Gleevec With Patient Savings Card Program 8/8/2016 6:53:39 AM
Apotex Launches Rosuvastatin Calcium Tablets Generic Version Of AstraZeneca PLC (AZN)'s Crestor 7/22/2016 10:58:34 AM
Apotex Launches First Generic Version Of Merck & Co. (MRK)'s Nasonex 3/22/2016 7:30:24 AM
Shakeup at Canada's Largest Pharma Firm Apotex 3/17/2015 6:00:37 AM
Apotex Inc. Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil) 2/18/2015 7:41:59 AM
Apotex Inc. Announces FDA Has Accepted For Filing Its Biosimilar Application For Pegfilgrastim 12/17/2014 9:16:55 AM
Apotex Inc. Sues Health Canada Over An ‘Unlawful’ Ban On Its Drugs 11/24/2014 6:14:16 AM